These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C. Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302 [Abstract] [Full Text] [Related]
6. Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Flick-Smith HC, Eyles JE, Hebdon R, Waters EL, Beedham RJ, Stagg TJ, Miller J, Alpar HO, Baillie LW, Williamson ED. Infect Immun; 2002 Apr 01; 70(4):2022-8. PubMed ID: 11895967 [Abstract] [Full Text] [Related]
7. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax. Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR. Infect Immun; 2009 Mar 01; 77(3):1197-207. PubMed ID: 19114543 [Abstract] [Full Text] [Related]
11. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use. Fasanella A, Tonello F, Garofolo G, Muraro L, Carattoli A, Adone R, Montecucco C. Vaccine; 2008 Oct 23; 26(45):5684-8. PubMed ID: 18775462 [Abstract] [Full Text] [Related]